US Patent for C1 US9650414B1 Granted
US Patent #9650414 “New classes of EP4 conjugate compounds -II; Dual Function Bone-targeting Peptide linked Pro-drugs” granted 2017-05-16. This covers MES1008. This Patent is owned by SFU and licensed exclusively to Mesentech Inc.